Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × Biological Specimen Banks × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Severe Combined Immunodeficiency 1 Rectal Neoplasms 1 Neuroblastoma 1 Mucopolysaccharidosis I 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Temozolomide 405 Radiotherapy 202 Bevacizumab 156 Radiation 80 Magnetic Resonance Spectroscopy 76 Lomustine 49 Surgical Procedures, Operative 45 Carmustine 41 pembrolizumab 40 Irinotecan 38 Nivolumab 32 Specimen Handling 27 Carboplatin 27 Radiosurgery 24 Erlotinib Hydrochloride 24 Chemotherapy, Adjuvant 23 Radiotherapy, Intensity-Modulated 22 Drug Therapy 22 Aminolevulinic Acid 20 Cyclophosphamide 19 O(6)-benzylguanine 17 sargramostim 16 Radiotherapy, Conformal 15 temsirolimus 14 Granulocyte-Macrophage Colony-Stimulating Factor 14 Everolimus 14 Blood Specimen Collection 14 Vorinostat 13 Sorafenib 13 Ipilimumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04657146 2025-11-12

LAMB-G

Duke University

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡